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Fibro-adipogenic progenitors (FAPs) are an interstitial cell population in adult skeletal muscle
that support muscle regeneration. During development, interstitial muscle connective tissue
(MCT) cells support proper muscle patterning, however the underlying molecular mechan-
isms are not well understood and it remains unclear whether adult FAPs and embryonic
MCT cells share a common lineage. We show here that mouse embryonic limb MCT cells
expressing the transcription factor Osr1, differentiate into ﬁbrogenic and adipogenic cells
in vivo and in vitro deﬁning an embryonic FAP-like population. Genetic lineage tracing shows
that developmental Osr1+ cells give rise to a subset of adult FAPs. Loss of Osr1 function leads
to a reduction of myogenic progenitor proliferation and survival resulting in limb muscle
patterning defects. Transcriptome and functional analyses reveal that Osr1+ cells provide a
critical pro-myogenic niche via the production of MCT speciﬁc extracellular matrix compo-
nents and secreted signaling factors.
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Skeletal muscles are composed of cells of different develop-mental origins. In vertebrate limbs, muscle ﬁbres as well asmuscle stem cells (termed satellite cells in the adult) origi-
nate from the somitic mesoderm1–3, while muscle connective
tissue (MCT) originates from the lateral plate mesoderm1, 2. A
mutual interdependence and cross-talk between both cell types
exist during developmental and adult regenerative myogenesis.
During development the myogenic progenitors migrate from the
somites to the nascent limb buds, where they form initial pre-
muscle masses that amplify and then subdivide into individual
muscles with each muscle having an individual shape and size4, 5.
It is widely accepted that vertebrate myogenic cells do not contain
intrinsic information that govern their place and time of
differentiation6, 7. Instead, there is long-standing evidence that
limb muscle patterning is mediated by extrinsic signals from local
lateral plate mesoderm derived cells8–10. This non-cell autono-
mous function is most likely mediated by MCT cells providing
local but still undeﬁned cues for myogenic cell proliferation,
differentiation, survival and local migration11–13.
MCT is often used as a collective term for different interstitial
cell types, i.e. cells that can be found between the myoﬁbres in
adult muscle. Muscle interstitial cells comprise Tcf4+ connective
tissue ﬁbroblasts that originate from lateral plate mesoderm12, 14,
but also diverse populations of mesenchymal progenitor cells
have been deﬁned15–18. The exact relationship between con-
nective tissue ﬁbroblasts and interstitial mesenchymal progenitors
is unclear and it was proposed that they largely overlap14, 19.
Amongst these progenitors, a population of non-myogenic ﬁbro-
adipogenic progenitors (FAPs) was identiﬁed that rapidly expand
upon muscle injury and promote myogenesis in vitro20, but also
give rise to ﬁbrosis and fatty inﬁltration in diseases21, 22. The pro-
myogenic function ascribed to FAPs during adult muscle regen-
eration is an intriguing parallel to the function lateral plate-
derived MCT progenitors play during embryonic myogenesis.
Whether or not FAPs and developmental MCT progenitors are
related and what molecular mechanisms contribute to their pro-
myogenic function is mostly unknown.
In this study we show that the transcription factor Odd
skipped-related 1 (Osr1) marks a subset of embryonic MCT cells
that constitute a developmental FAP-like population, which
supports embryonic myogenesis and is also a developmental
source of adult muscle interstitial FAPs. We further show that
loss of Osr1 function during limb development leads to a marked
decrease in myogenic progenitor expansion and muscle pattern-
ing defects. Consistent with these observations, we show that
Osr1 lies upstream of a large number of genes that control muscle
connective tissue function.
Results
Osr1 marks a subpopulation of limb MCT cells. Osr1 is
expressed in MCT cells in chick embryos and is involved in chick
connective tissue differentiation23, 24. In mice, Osr1 expression
can be followed via an eGFP-IRES-CreERt2 knock-in allele
(Osr1GCE)25 and was found in embryonic limb mesenchyme
correlating with areas of myogenic differentiation between E11.5
and E13.5 (Fig. 1a–e, Supplementary Fig. 1a). Apart from the
limbs, Osr1+ interstitial cells were also observed in and sur-
rounding other muscles as the shoulder girdle muscles and
superﬁcial as well as deep muscles of the back (Supplementary
Fig. 1b). Not all muscles harbour Osr1+ interstitial cells; low GFP
signal was seen, for example, in intercostal muscles (Supple-
mentary Fig. 1b). In addition, the diaphragm and the tongue
contained Osr1+ interstitial cells (Supplementary Fig. 1c). In the
limbs, Osr1+ cells were observed in close association with Lbx1+
and Pax7+ myogenic progenitors (Fig. 1a, b), closely associated
with but distinct from Myod1+ myoblasts (Fig. 1c) and differ-
entiating myoﬁbres (Fig. 1d). At E14.5, Osr1+ cells were found in
an interstitial position between myoﬁbres (Fig. 1e). The Osr1-GFP
expression pattern was similar to that of Osr1 transcripts (Fig. 1f).
Osr1 expression was independent of the presence of myogenic
cells as shown by normal Osr1 expression in muscleless limbs of
Pax3GFP/GFP mutant mice (Fig. 1f, Supplementary Fig. 2).
Freshly FACS-isolated Osr1+ cells from E13.5 Osr1GCE/+
embryonic limbs (Fig. 1g) expressed ﬁbroblastic markers,
including type I Collagen (COL1), PDGFRα, Vimentin, type VI
Collagen (COL6) and alpha-smooth muscle actin (αSMA)
(Fig. 1h). This ﬁbroblastic signature was maintained in cultures
with standard growth medium (Fig. 1i). Consistent with these
observations, mRNA-sequencing (RNA-Seq) data from Osr1GCE/
+ cells revealed that freshly isolated Osr1+ cells strongly express
genes encoding ECM components characteristic of ﬁbroblasts
(Supplementary Table 1). To exclude Osr1 expression in a small
subset of myogenic cells or low-level expression in myogenic cells,
we FACS-isolated limb mononuclear cells divided into Osr1-
expressing (GFP+) and Osr1-negative (GFP−) populations
(Supplementary Fig. 3a) and analysed myogenic marker expres-
sion after cytospin. Myf5+ or Myogenin+ cells were only found in
the GFP− FACS fraction, anti-GFP antibody labelling did not
identify any GFP+/Myf5+ or GFP+/Myogenin+ cells (Supplemen-
tary Fig. 3b). Altogether, this establishes that Osr1 is a marker for
a subpopulation of mouse limb MCT cells.
Osr1+ MCT population partially overlaps with Tcf4. Tcf4
(Tcf7l2) is a recognised marker for embryonic MCT cells11, 12,
however less than 60% of FACS-isolated Osr1+ cells showed Tcf4
expression at E13.5 (Fig. 1h, i), indicating that limb MCT is a
heterogeneous entity that contains distinct subpopulations. We
then compared the expression of Osr1 and Tcf4 in E11.5 and
E13.5 hindlimbs (Fig. 2a, b). At E11.5 Osr1 and Tcf4 were
expressed in limb mesenchyme ﬂanking the cartilaginous con-
densation of the humerus (Fig. 2a). The Osr1 or Tcf4 expression
domains partially overlapped, cells expressing both transcription
factors were found, but also cells expressing either Osr1 or Tcf4
exclusively (Fig. 2a). Osr1 was also expressed in mesenchyme
ﬂanking the scapula condensation, where Tcf4 was not expressed
(Fig. 2a). At E13.5, Osr1 and Tcf4 showed distinct expression
patterns in hindlimbs, although with areas of coexpression
(Fig. 2b). Osr1 was generally found more towards the periphery,
while Tcf4 was prevalent in central regions. The biceps femoris
muscle exclusively harboured Osr1+ cells, the ﬂexor digitorum
longus muscle exclusively harboured Tcf4+ cells. Interstitial cells
coexpressing Osr1 and Tcf4 were, for example, observed in the
gastrocnemius and tibialis anterior muscles. The gastrocnemius
interstitial cells showed higher Osr1, the tibialis anterior inter-
stitial cells higher Tcf4 expression at this stage (Fig. 2b).
We next analysed the relationship of Osr1 and Tcf4 expression
at later developmental stages. To this end we isolated foetal
(E18.5) Osr1-expressing and Osr1-negative (GFP+ and GFP−)
interstitial cells from dissected hindlimb muscles by FACS (CD45
−;CD31−;Ter119−; α7-integrin− to remove satellite cells) and
analysed Tcf4 expression in GFP+ and GFP− fractions via
immunolabelling after cytospin. The majority of the GFP+ cells
were Tcf4+ (72,9%). The GFP− fraction harboured apparently less
Tcf4+ cells (64,3%). The low overlap of both markers at E13.5
(Fig. 1h, Fig. 2b) suggests that Osr1+ cells acquire Tcf4 expression
during development. In addition, the majority of the GFP+ cells
were positive for PDGFRα (72,1%), while the GFP− pool was
clearly reduced for PDGFRα+ cells (43,7%; Fig. 2c). Of all Tcf4+
cells (i.e. within GFP+ and GFP− populations), 66,4% expressed
PDGFRα (Fig. 2c). This establishes that neither Tcf4 nor Osr1 are
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Fig. 1 Osr1 is expressed in limb mesenchymal cells associated with myogenic cells and labels MCT cells. a–e Osr1 expression was assessed by
immunolabelling for GFP on Osr1GCE/+ embryos at the indicated stages. Osr1+ cells are found interstitial to Lbx1+, Pax7+ and MyoD1+ myogenic progenitors
and interstitial to developing myoﬁbres labelled either for Myosin heavy chain (MyHC) or Laminin. Note that in some developing muscles Osr1+ cells are
abundant, while being scarce in others. Boxed regions (numbered in a) are shown in the panels to the right of overview images and are magniﬁcations of
the area. f Osr1 expression was analysed by in situ hybridization to sections of muscleless limbs of E11.5 (left), 12.5 (middle) and 13.5 (right) Pax3 mutant
embryos. The overall expression pattern of Osr1 is similar in limbs of Pax3GFP/+ and Pax3GFP/GFP embryos. Arrows highlight strong Osr1 expression observed
in control and muscleless limbs. Boxed regions are shown in the panels to the right of overview images and are magniﬁcations of the area. g Schematic
depiction of limb Osr1+ cell isolation procedure and examples of FACS plots. h Expression of ﬁbroblastic markers in freshly FACS-isolated Osr1+ cells
subjected to cytospin. (n= 3). i Osr1+ cells cultured in growth medium maintained the expression of ﬁbroblastic markers (n= 3). Insets in h, i are
percentage of COL1+, PDGFRα+, Vimentin+, Pan-COL6+, αSMA+ and Tcf4+ cells among the Osr1+ cell population. Values represent mean± s.e.m.
N-numbers indicate biological replicates, i.e. samples from different specimen
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comprehensive MCT cell markers, but indeed appear to identify
region-speciﬁc subpopulations of MCT in development.
Osr1+ cells are developmental ﬁbro-adipogenic progenitors.
Limb lateral plate derived cells are a heterogeneous population
exhibiting multiple differentiation potentials. We therefore ana-
lysed the differentiation potential of the Osr1+ cell population.
FACS-isolated Osr1+ cells exposed to ﬁbrogenic, adipogenic,
chondrogenic, osteogenic or myogenic conditions in vitro, dis-
played robust ﬁbrogenic and adipogenic differentiation, whereas
Osr1+ cells displayed very low chondrogenic and no detectable
osteogenic or myogenic potentials (Fig. 3a). To analyze Osr1+ cell
differentiation in vivo, we pulsed Osr1GCE/+;R26RmTmG embryos
with a single dose of Tamoxifen (TAM) at E11.5 or E13.5 fol-
lowed by analysis after organogenesis (E18.5). This in vivo genetic
Osr1+ cell lineage tracing showed a contribution of Osr1+ cell
progeny in limb muscle interstitial regions and dermis at E18.5
(Fig. 3b, Supplementary Fig. 4a). Consistent with in vitro adi-
pogenic differentiation (Fig. 3a), Osr1+ cell progeny were
observed in subcutaneous white adipose tissue in vivo (Fig. 3b,
Supplementary Fig. 4a).
As shown above, speciﬁc muscles harbour different amounts of
Osr1+ cells (Fig. 2b). We thus analysed the contribution of E11.5
Osr1+ cells to PDGFRα+ and Tcf4+ interstitial cells in the
gastrocnemius muscle as an example for high Osr1 expression,
and the tibialis anterior as an example for lower Osr1 expression.
As expected, Osr1 descendants labelled by a single TAM dosage
at E11.5 contributed stronger to PDGFRα+ or Tcf4+ interstitial
cells in gastrocnemius than tibialis anterior (Fig. 3c). Taken
together, our data reveal that Osr1+ cells represent spatially
allocated mesenchymal progenitors with ﬁbrogenic and adipo-
genic fates during development resembling adult muscle inter-
stitial FAPs20, 21.
Adult mouse FAPs are characterized by expression of the surface
markers Sca1 (Ly6A/E)20 or PDGFRα21, 22. PDGFRα was also used
for FAP selective isolation from human muscles26. In addition to
these markers, adult FAPs share CD34 with satellite cells20 and
CD29, CD90 and CD166 with mesenchymal stem cells (MSCs)
21, 26. FAPs were thus proposed to constitute a muscle-speciﬁc and
lineage-restricted form of MSC16, although this relation awaits
clariﬁcation. To further elucidate the relationship of embryonic
(E13.5) Osr1+ cells with adult FAPs and MSCs, we analysed their
surface marker proﬁle. E13.5 Osr1+ cells were mostly positive for
PDGFRα (Fig. 1h, Supplementary Fig. 5a, b). Osr1+ cells were
positive for CD29, CD166 and mostly negative for CD90. In
addition, Osr1+ cells were positive for the MSC markers CD73,
Tcf4+ in GFP+ 72.9% ± 5.75%
PDGFRα+ in GFP+ 72.1% ± 4.06%
PDGFRα+ in GFP– 43.7% ± 6.4%
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Fig. 2 Osr1 and Tcf4 identify distinct and common MCT cells. a, b Osr1 expression was assessed by immunolabelling for GFP on E11.5 and E13.5 Osr1GCE/+
embryos. Boxed regions are shown in the numbered panels below and are magniﬁcations of the area. a At E11.5 Osr1 is expressed in limb mesenchyme at
the level of the humerus condensation overlapping with Tcf4. Tcf4 is expressed towards the centre and Osr1 towards the periphery of the limb. b At E13.5
Osr1 is expressed in limb mesenchyme in the periphery and encompassing the biceps femoris (bf), gastrocnemius (gc), soleus (so), plantaris (pa),
semimembranosus (sm), peroneus longus (pl), extensor digitorum longus (edl) and tibialis anterior (ta) muscles. Tcf4 is expressed in central areas of the
limb, where it is exclusive in the ﬂexor digitorum longus (fdl) muscle, and within and surrounding the edl and ta muscles. c E18.5 limb muscle interstitial
cells were FACS-isolated as indicated and separated into Osr1-expressing and Osr1-negative (GFP+ and GFP−) populations. Cytospun cells were labelled for
Tcf4 and PDGFRα. Quantiﬁcation showing the percentages of PDGFRα+ and Tcf4+ cells in GFP+ or GFP− populations is shown below. Percentage of
PDGFRα cells in all Tcf4 cells was counted in both GFP+ and GFP−populations (n= 3). Values represent mean± s.e.m (n= 3). N-numbers indicate
biological replicates, i.e. samples from different specimen
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CD105 and CD106, but negative for CD44 and CD146 (Supple-
mentary Fig. 5a). The expression of cell surface markers was in part
paralleled by their mRNA abundances in Osr1+ cells (Supplemen-
tary Table 2). Altogether the Osr1+ cell surface marker proﬁle
strongly overlaps with that of FAPs and MSCs. However,
embryonal Osr1+ cells were negative for Sca1 and CD34
(Supplementary Fig. 5a). This is in line with embryonic expression
of Sca1 conﬁned to the tail and aorta-gonad-mesonephros region27,
and apparent CD34 expression exclusively in endothelium (Eurex-
press database http://www.eurexpress.org)28 at that stage.
We then analysed FACS-isolated foetal E18.5 muscle inter-
stitial cells (CD45−;CD31−;Ter119−;α7-integrin−) for Sca1
expression and found that a small population of Sca1+ cells
could be detected at this stage (Supplementary Fig. 6a). Intrigu-
ingly, Osr1+ cells were equally distributed between Sca1− and
Sca1+ MCT cells (Supplementary Fig. 6a). It is therefore possible
that Osr1+ cells gain Sca1 expression over time. We then tested
adult CD45−,CD31−, Ter119−, a7-integrin−, Sca1+ FAPs20 for
GFP expression and found very low GFP expression (close to the
detection limit) in a small fraction of FAPs, but not in the other
interstitial cell populations (Supplementary Fig. 6b). Analysing the
expression of Osr1-GFP over time showed that expression of Osr1
declined in muscle interstitial cells soon after birth (Supplemen-
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Fig. 3 Osr1+ cells are embryonic ﬁbro-adipogenic progenitors. a Cultures of Osr1+ cells under ﬁbrogenic, adipogenic, chondrogenic, osteogenic or myogenic
conditions. Fibrogenic differentiation was assessed by COL1 immunolabelling, cells exhibited stretched myoﬁbroblast morphology. Adipogenic
differentiation was assessed by Oil Red O staining, chondrogenic and osteogenic differentiation was assessed by Alcian blue and Alizarin red staining,
respectively and myogenic differentiation was tested by immunolabelling for Myod1 and MyHC. Osr1+ cells show ﬁbrogenic and adipogenic differentiation,
but no osteogenic or myogenic differentiation. GFP− FACS-sorted cells (Osr1−) containing osteo-chondrogenic and myogenic progenitors were used as
controls (inserts). b Osr1 cell lineage tracing in E18.5 Osr1GCE/+;R26RmTmG/+ embryos after Tamoxifen induction at E11.5. Membrane eGFP (mG) positive
cells represent Osr1+ cell progeny. Schematic depiction of Osr1GCE/+;R26RmTmG/+-based lineage tracing during development is shown above. Osr1+
progenitors give rise to muscle interstitial cells, dermis cells embedded in Collagen type I-rich matrix, and adipocytes immunolabelled for Fatty acid binding
protein 4 (FABP4) in axillary and inguinal white fat pads. Ed= epidermis, der= dermis. c Osr1 cell lineage tracing in E18.5 Osr1GCE/+;R26RmTmG/+ embryos
after Tamoxifen induction at E11.5 as in b. Lineage contribution of Osr1 descendants (mG+) to PDGFRα and Tcf4 cells was analysed in the gastrocnemius
and tibialis anterior muscles. Quantiﬁcation is shown below (n= 3). Values represent mean± s.e.m. N-numbers indicate biological replicates, i.e. samples
from different specimen
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in vivo ﬁbro-adipogenic differentiation potentials of Osr1+ cells,
we conclude that Osr1+ cells correspond to an embryonic FAP-
like population that feeds into ﬁbrous and adipose tissues during
development. The acquisition of Sca1 expression seen in Osr1+
cells at E18.5 indicate a direct continuum between Osr1+
developmental cells and adult Sca1+ FAPs.
Developmental Osr1+cells are a source of adult FAPs. We next
used long-term genetic lineage tracing to determine whether adult
FAPs are the lineage progeny of developmental Osr1+ cells.
Shortly after birth, interstitial PDGFRα+ cells still abundantly
express Osr1 in muscles like the gastrocnemius (Fig. 4a). Genetic
labelling of Osr1+ cells at birth (TAM at p0 and p1) resulted in
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positive labelling for muscle interstitial PDGFRα+ cells in the adult
(Fig. 4b). Next, we FACS isolated adult FAPs according to Joe
et al.20 from whole hindlimb muscles of Osr1GCE/+;R26mTmG or,
as negative control, Osr1+/+;R26mTmG animals Tamoxifen-
induced at p0/p1. FAPs (CD45−;CD31−;Ter119−;Sca1+;CD34+),
satellite cells (CD45−;CD31−;Ter119−;Sca1−;CD34+) and osteo-
chondrogenic cells (CD45−;CD31−;Ter119−;Sca1−;CD34−) were
analysed for mGFP positive cells. Osr1 progeny was observed
exclusively in FAPs, while no lineage progeny was found in
satellite cells or osteo-chodrogenic progenitors (Fig. 4c) showing
that Osr1+ progenitors only contribute to the FAP pool. Analysis
of cytospun mGFP+ and mGFP− FAPs showed that almost all
mGFP+ cells are PDGFRα+. In addition, mGFP+ and mGFP−
FAPs harbour a high proportion of Tcf4+ cells (Fig. 4d). The
mGFP+ population interestingly appeared enriched for both
markers (Fig. 4d). To conﬁrm these ﬁndings, the progeny of Osr1+
cells was analysed on sections of gastrocnemius and tibialis
anterior muscles and, as an example for a non-limb muscle, the
diaphragm. 21% (TA), 26% (gastrocnemius) and 35% (dia-
phragm) of interstitial PDGFRα+ cells originated from develop-
mental Osr1+ cells pulsed at p0/p1 (Fig. 4e). In addition, Osr1+
progenitors also contributed to different extent to Tcf4+ cells
(Fig. 4e). This correlates with the embryonic lineage tracing results
obtained for the TA and gastrocnemius muscles at E18.5 (Fig. 3c)
and suggests that the level of Osr1+ cell contribution to adult FAPs
in individual muscles is reﬂected by the developmental Osr1
expression pattern. Altogether, this establishes that adult FAPs
derive, at least in part, from developmental Osr1+ cells.
Osr1 regulates embryonic myogenesis. Given the supportive
function of adult FAPs in regenerative myogenesis and the non-
cell autonomous function ascribed to limb MCT cells during
muscle development, we asked whether Osr1+ FAP-like cells have
a similar supportive function during embryonic myogenesis.
Homozygous Osr1GCE/GCE mutants die between E14.5 and E15.5
due to heart defects29, which allowed us to analyse embryonic
myogenesis. 3D reconstruction of limb muscles at E14.5 revealed
speciﬁc muscle patterning defects in Osr1 mutants. In hindlimbs,
stylopod muscles were truncated (Fig. 5a). The biceps femoris
accessory and posterior head muscles were shortened and myo-
ﬁbres were misoriented compared to wildtype (Fig. 5a). Sections
showed a complete absence of myogenic cells in distal areas of the
biceps femoris (Fig. 5b), suggesting that muscle progenitors either
failed to reach the distal positions or did not survive. In contrast
to muscle truncation, scattered ectopic myogenic cells and muscle
ﬁbres were observed between muscles (Fig. 5c, Supplementary
Fig. 7c, d). Several other muscles of hind- and forelimbs as well as
the shoulder and pelvic girdle were variably affected (Supple-
mentary Fig. 7a–e). Overall muscles showing high Osr1 expres-
sion such as the biceps femoris (Fig. 5a) or gastrocnemius muscles
(Supplementary Fig. 7e) showed clear aberrations, while muscles
with low Osr1 expression as the tibialis anterior, extensor digi-
torum longus or peroneus longus muscles appeared mostly
unaffected (Supplementary Fig. 7d).
Myod1 and Myog (Myogenin) expression in E13.5 forelimbs
showed defects in size, shape and/or trajectory of individual
muscle anlagen in Osr1 mutants (Fig. 5d, Supplementary Fig. 7f).
In addition, nascent muscle mass anlagen were less sharply
deﬁned as compared to wildtype mice (Fig. 5d). This was already
noticeable at earlier stages of development (E11.5), where
myogenic cells were present in regions that normally do not
contain myogenic cells, and myogenic anlagen displayed a
reduced myogenic cell density per area in Osr1 mutants
(Supplementary Fig. 8a). This indicates a partial misdistribution
of myogenic cells in Osr1 mutants in line with the local lack of
myoblasts or local appearance of ectopic myoblasts shown above.
Maintenance and ampliﬁcation of the initial myogenic progenitor
pool is essential for correct muscle patterning. In Osr1 mutant
limbs, the myogenic progenitor pool was reduced at E11.5 and
E13.5 compared to respective wildtypes (Fig. 5e, Supplementary
Fig. 8b, e). The number of myogenic progenitors was equally
reduced in the proximal as well as dorsal and ventral limb muscle
masses at E11.5 indicating that the initial migration step of
muscle progenitors was not overtly impaired (Fig. 5e). A
measurement of the ratios of Pax7+ vs. Myod1+ cells or Pax7
+/Myod1+ cells vs total Pax7+ cells showed no difference during
early myogenic differentiation in Osr1 mutants at E11.5
(Supplementary Fig. 8b) indicating that the reduction in the
number of myogenic cells was not caused by precocious
differentiation. Myogenic cells (Lbx1+, Pax7+, Myod1+) of E11.5
(Fig. 5f, Supplementary Fig. 8c, d) and E13.5 (Supplementary
Fig. 8f) Osr1 mutants showed a decreased proliferation rate. In
addition, myogenic cells showed a signiﬁcantly increased
apoptotic rate in E11.5 Osr1 mutants as compared to wildtype
(Fig. 5g). We conclude that a loss of Osr1 function in embryonic
FAPs leads to limb muscle patterning defects. These defects are
preceded by a reduction of the muscle progenitor pool caused by
decreased proliferation and survival of myogenic cells in
combination with a misdistribution of myogenic cells. The limb
muscle phenotype was not caused by an absence of Osr1+ cells
(Supplementary Fig. 7g, h).
Osr1 maintains muscle connective tissue identity. To identify
Osr1 target genes underlying the non-cell autonomous effect of
Osr1+ cells on muscle formation, we analysed the transcriptome
of E13.5 Osr1GCE/GCE cells vs. Osr1GCE/+ cells. We identiﬁed 511
differentially expressed (DE) genes (Fig. 6a). Gene ontology (GO)
analysis for “cellular component” highlighted enrichments for
“extracellular region” and “extracellular matrix” related genes
(Fig. 6b). Consistently, KEGG analysis of all DE genes yielded
enrichment for “ECM-receptor interaction” (Supplementary
Fig. 9a). Interestingly, genes belonging to the ECM cluster showed
a bipartite behaviour with approximately half of the genes being
down-regulated or up-regulated (Fig. 6c). Analyses of gene
expression using the Eurexpress database28 revealed predominant
expression of ECM genes that were upregulated in Osr1 deﬁcient
cells in cartilage and/or tendons. In accordance, GO analysis of
upregulated genes revealed a signiﬁcant enrichment for “skeletal
Fig. 4 Developmental Osr1+ cells are a source for adult FAPs. a Osr1 is expressed in PDGFRα+ interstitial mesenchymal progenitors at birth (postnatal day
P0). b Osr1 cell lineage tracing in adult (P84/12 week) Osr1GCE/+;R26RLacZ/+ animals after Tamoxifen induction at P0. Osr1+ cell progeny is marked by
immunolabelling for beta-Galactosidase (bGal). Perinatal Osr1+ cells give rise to interstitial PDGFRα+ FAPs. c Osr1 cell lineage tracing in adult (12 week)
Osr1GCE/+;R26mTmG/+ animals after Tamoxifen induction at P0; Osr1+/+;R26mTmG/+ animals used as controls are shown left. FAPs (Sca1+, CD34+), satellite
cells (SAT) and double-negaitve cells (DN) were FACS-isolated and analysed for mGFP expression. Only FAPs contained a clearly detectable mGFP+
population (n= 3). dmGFP+ and mGFP− FAPs isolated as in c were cytospun and analysed for PDGFRα and Tcf4 expression. Quantiﬁcation is shown below
(n= 3). e The contribution of p0 Osr1+ cells to muscle interstitial PDGFRα+ and Tcf4+ cells was quantiﬁed on sections of Osr1GCE/+;R26mTmG/+ animals in
the indicated muscles. Quantiﬁcation is shown below (n= 4). Values represent mean± s.e.m. N-numbers indicate biological replicates, i.e. samples from
different specimen
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Fig. 5 Limb muscle patterning defects in Osr1-deﬁcient embryos. a Muscle pattern in hindlimbs of E14.5 Osr1+/+ and Osr1GCE/GCE embryos assessed by
whole limb immunolabelling for Myosin heavy chain (MyHC) followed by 3D reconstruction. Affected muscles are highlighted by false colours. Note
truncations of several muscles. Scale bars: 100 μm. b Sections of E13.5 hindlimbs, where the Biceps femoris muscle is highlighted. Section planes are
indicated in green muscles (a, bottom right) by the dashed lines. The distal truncated region of the B. femoris muscle is devoid of myogenic cells in Osr1
mutants highlighted with dashed lines. In the residual B. femoris muscle of Osr1 mutants, myogenic cells appear in disarray (see high magniﬁcations).
Analysis was done on serial sections of whole limbs to exclude section artefacts. c Ectopic Myod1+ myoblasts and MyHC+ myoﬁbers between the Extensor
digitorum longus (EDL) and Peroneus longus (PL) muscles in Osr1 mutants (yellow arrows). d Wholemount in situ hybridization on E13.5 Osr1+/+ or
Osr1GCE/GCE embryos for myogenic markers Myod1 and Myog. Misshaped muscle primordia in limbs (white arrows), disarrayed myoﬁbres in the latissimus
dorsi muscle (yellow arrows) and ectopic myoblasts (red arrows) are observed in Osr1 mutants. e Immunolabelling for Lbx1 and Myod1 on E11.5 limb
sections shows a decrease in the overall number of myogenic cells in proximal, dorsal and ventral muscle primordia in mutant compared to wt embryos (n
= 3). f Reduced proliferation rate of Lbx1+ myogenic progenitors (dorsal: wt 38,6±2,3%, mut 30±1,8%; ventral: wt 41,1±1,3%, mut 29,6±1,0%) in E11.5 Osr1
mutants assessed by BrdU labelling (n= 4). (g) Increased apoptosis in myogenic cells in Osr1mutants assessed by immunolabelling for cleaved (activated)
Caspase 3 (c-Casp3) (n= 3). Error bars represent s.e.m. T-test: *=p< 0.05; **=p< 0.01; ***=p< 0.001. N-numbers indicate biological replicates,
i.e. samples from different specimen
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development” and “cartilage development” (Supplementary
Fig. 9b). Therefore, we systematically mined the DE genes
for genes connected to the GO term “cartilage development” and
for tendon genes based on the list identiﬁed by Havis et al.30.
All identiﬁed tendon and cartilage genes were upregulated in
E13.5 Osr1-KO cells compared to Osr1 heterozygous cells
(Fig. 6d), which was conﬁrmed by RT-qPCR for selected genes
(tendon: Scx, Tnmd, Mkx; osteo-chondrogenic: Runx2, Sox5,
Sox9) (Fig. 6e). This gene deregulation was, with the exception of
Scx, already detectable at E11.5 (Fig. 6e). Accordingly, Osr1
deﬁcient cells (Osr1GCE/GCE) showed a higher chondrogenic
capacity than Osr1GCE/+ cells in vitro (Fig. 6f). These data are
consistent with the presence of ectopic cartilage differentiation in
synovial joints in Osr1 and Osr2 double mutants31, a requirement
for Osr1 in preventing Sox9 expression and ectopic cartilage
formation in the neural crest32 and the ability of Osr1 to repress
tendon and cartilage differentiation in chick limb mesenchymal
cells23. We note that we also observed signs of ectopic tendon
differentiation in Osr1 mutants speciﬁcally between the myo-
tendinous junctions of the Teres major and Triceps brachii
lateralis muscles (Supplementary Fig. 10a). Overall, Scx showed
apparently increased and less conﬁned expression in E13.5
Osr1GCE/GCE limbs compared to control limbs (Supplementary
Fig. 10b).
In contrast to the upregulated cartilage/tendon ECM genes,
ECM genes that were downregulated in Osr1 deﬁcient cells were
expressed predominantly in irregular CT and/or MCT (based on
Eurexpress data). These ECM genes encoded e.g. for collagens
associated to MCT, such as COL6 (Fig. 6c, Fig. 7a). COL6,
typically consisting of COL6A1, COL6A2 and COL6A3 chains, is
an indispensable component of the muscular ECM mutated in
human muscular dystrophies33. Furthermore COL6 has a central
role in ECM assembly, since it bridges ﬁbrillary collagens, matrix
components and cell adhesion molecules33. Other CT ECM
components were downregulated in Osr1 mutant cells (Fig. 6c,
Fig. 7a), including members of the small leucine-rich proteogly-
can (SLRP) family such as Lumican (Lum) and Decorin (Dec)
that play a role in ECM assembly and cell-matrix interaction34, or
the basement membrane component Nidogen 2 (Nid2). The
downregulation of selected ECM genes (Col3a1, Col5a3, Col6a1,
Col6a2, Col6a3, Dcn, Lum, Nid2) was conﬁrmed by RT-qPCR
(Fig. 7b). Immunolabelling for pan-COL6 revealed a strong
reduction of COL6 abundance in E13.5 Osr1GCE/GCE limbs as
compared to wildtype (Fig. 7c).
We then tested which ECM genes may be direct targets of Osr1
via Chromatin immunoprecipitation (ChIP). For this purpose
freshly isolated MEFs from E13.5 C57Bl6 limbs were stably
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Fig. 6 Osr1 controls ECM gene expression in a bimodal way and is required to prevent ectopic cartilage / tendon gene expression. a Volcano plot depiction
of transcriptome analysis of FACS-sorted Osr1+ cells from limbs of E13.5 Osr1GCE/+ or Osr1GCE/GCE embryos shows differentially expressed (DE) genes
between Osr1GCE/+ and Osr1GCE/GCE limb cells. 511 DE genes were identiﬁed with a false discovery rate of 0,05 that showed a log2 fold change over 1,2 or
below 0,8 and a Benjamini-Hochberg adjusted p-value (padj)< 0,1. b GO analysis of all DE genes for “cellular component” showed enrichment for the
indicated terms. c Heatmap depiction of all genes belonging to the term “extracellular matrix” (ECM). Selected ECM genes are indicated. d Bar graph plot
for genes selected from all DE genes for their cartilage and/or tendon- speciﬁc expression pattern in embryo; note that all cartilage/tendon genes are
upregulated in Osr1 mutants. e Conﬁrmation of upregulation of Runx2, Sox5 and Sox9 (cartilage genes) and Scx, Mkx and Tnmd (tendon genes) in E11.5 and
E13.5 Osr1 deﬁcient cells by RT-qPCR (n= 4). f Chondrogenic culture of Osr1GCE/+ and Osr1GCE/GCE cells. Chondrogenic matrix is stained with Alcian blue,
histomorphometric quantiﬁcation is shown on the right. (n= 3). Error bars represent log2 fold change standard error (ifcSE) estimated by DESeq2 in d and
s.e.m. in e, f. T-test: *=p< 0.05; **=p< 0.01; ***=p< 0.001. N-numbers indicate biological replicates, i.e. samples from different specimen
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at the 3′ end to a tripleFLAG tag under control of the low-active
Ubiquitin C (UbC) promoter. This yielded mild overexpression
(approximately twofold) of Osr1-tripleFLAG mRNA (Fig. 7d),
which was chosen to avoid overexpression artefacts. Mild
overexpression of Osr1 in MEFs was sufﬁcient to increase the
expression of Col6a1, Col6a3 and Lum mRNAs (Fig. 7e). For
ChIP, upstream regions of Col6a1, Col6a3 and Lum were
screened for the presence of Osr1 consensus binding sites35, 36
in the UCSC Genome Browser37. Two putative binding sites were
found upstream of Col6a1, Col6a1 or Lum, respectively. ChIP
yielded signiﬁcant enrichment for one binding site at each the
Col6a1 and the Col6a3 loci in comparison to ﬂanking control
regions without consensus binding sites (Fig. 7e, f; primer
sequences for putative binding sites and controls are provided in
Supplementary Table 7). These data support a direct regulation of
Col6a1 and Col6a3 by Osr1. Taken together, our data support a
role for Osr1 in promoting the expression of MCT-speciﬁc ECM
components, while inhibiting tendon and cartilage ECM and
transcription factor genes. Given that Osr1+ cells display high











































































































































































































































































Fig. 7 Osr1 is required for muscle connective tissue ECM gene expression. a Bar graph plot of genes selected from all DE genes by their expression
associated with muscle connective tissue; most of the genes belong to the downregulated cluster in (Fig. 6c). b Conﬁrmation of downregulation of selected
MCT-ECM genes in E11.5 and E13.5 Osr1 deﬁcient cells by RT-qPCR (n= 4). c Immunolabelling for MyHC and COL6 shows reduced abundance of COL6 in
Osr1 mutants. d Transduction of E13.5 MEFs with lentiviral particles causes mild overexpression of Osr1. e Lentiviral overexpression of Osr1 causes
upregulation of Col6a1, Col6a3 and Lum genes. f Chromatin immunoprecipitation of putative Osr1 binding sites at the Col6a1 and Col6a3 loci. Above:
schematic representation of the loci; positions of Osr1 binding sites and PCR primers relative to exon 1 of the Col6a1 and Col6a3 genes are indicated. Below:
representative gel pictures of ChIP vs. input are shown left, conﬁrmation of binding site pulldown via RT-qPCR (n= 3) are shown right. Bs: putative binding
site, No Bs: control region. Size marker: 100 base pair ladder; band sizes are indicated in base pairs. Error bars represent log2 fold change standard error
(ifcSE) estimated by DESeq2 in a and s.e.m. in (b, d, e, f). T-test: *=p< 0.05; **=p< 0.01; ***=p< 0.001. N-numbers indicate biological replicates, i.e.
samples from different specimen in b or independent assays in d, e, f
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key transcription factor that maintains embryonic Osr1+ FAP cell
identity. Loss of Osr1 in turn leads to a shift in embryonic FAP
transcriptional activity from an ECM characteristic for MCT to
cartilage/tendon ECM.
Osr1+ cells are a source of secreted signalling molecules. In
addition to MCT-ECM components, we searched for DE genes
encoding secreted signalling molecules in Osr1-deﬁcient cells. GO
analysis of all DE genes or only downregulated genes for
“biological processes” showed similar enrichment for the terms
“response to wounding”, “immune response” and “chemotaxis”
(Fig. 8a, Supplementary Fig. 9c). Consistently, KEGG analysis
of all DE genes or only downregulated genes showed enrichment
for “chemokine signalling” and associated pathways (Fig. 8b,
Supplementary Fig. 9a). Consistently, genes associated with
these terms, containing many members of chemokine family,
were mostly downregulated in Osr1 mutants (Fig. 8c), as were
genes encoding several other myogenesis-related signalling
factors such as Bmp4 (Fig. 8d). The decrease in expression levels
of Cxcl12 and Bmp4 mRNAs was conﬁrmed by RT-qPCR in
Osr1+ cells (Fig. 8e). Overexpression of Osr1 induced an increase
in Cxcl12 mRNA in MEFs (Fig. 8f). The Cxcl12 locus showed
one consensus Osr1 binding site approx. 18 kb upstream and two
distant upstream consensus binding sites within DNAseI
hypersensitive regions (UCSC) in the gene desert 5′ of Cxcl12.
A distant 5′ element located approx. 400 kb upstream of Cxcl12
was bound by Osr1 (Fig. 8g; primer sequences are provided
in Supplementary Table 7). Together this indicated direct reg-



































































































































































































































































































Fig. 8 Osr1 cells are a source or growth factor signalling and Osr1 directly controls Cxcl12 expression. a Gene ontology (GO) analysis for “biological process”
using all deregulated (DE) genes (Osr1GCE/+ vs. Osr1GCE/GCE cells) showed signiﬁcant enrichment for the indicated terms. b KEGG pathway analysis of
downregulated genes. c Heatmap depiction of all non-redundant DE genes contained in the GO terms shown in c collectively termed “immune processes”.
Several genes for signalling molecules from chemokine families appear downregulated in Osr1GCE/GCE limb cells. d Deregulation of secreted signalling
molecules selected from all DE genes for their previously demonstrated role in myogenesis. e Conﬁrmation of downregulation of Cxcl12 and Bmp4 in Osr1-
deﬁcient cells isolated at E11.5 and E13.5 by RT-qPCR (n= 5). f Upregulation of Cxcl12 upon lentiviral Osr1 overexpression. g Chromatin
immunoprecipitation (ChIP) for a putative Cxcl12 enhancer. Representative gel pictures of ChIP vs. input are shown below schematic representation of the
locus, conﬁrmation of binding site pulldown via RT-qPCR (n= 3) shown right. Bs: putative binding site, No Bs: control region. DNAse HSS: DNAseI
hypersensitive regions according to UCSC. Size marker: 100 base pair ladder; band sizes are indicated in base pairs. Error bars represent log2 fold change
standard error (ifcSE) estimated by DESeq2 in d and s.e.m. in e, f, g. T-test: *=p< 0.05; **=p< 0.01. N-numbers indicate biological replicates, i.e. samples
from different specimen in e or independent assays in f, g
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Osr1+ FAPs provide a myogenic niche in developing limbs. The
transcriptional aberrations in Osr1 deﬁcient cells were in part
observed as soon as E11.5 concomitant with the reduced myo-
genic cell pool. A signiﬁcant downregulation at E11.5 was found
for the MCT-ECM genes Col6a3, Lum, Dcn and Nid2. In contrast,
Col3a1, Col5a3, Col6a1 and Col6a2 showed no signiﬁcant
difference in Osr1+ cells isolated at E11.5 (Fig. 6b). However,
COL6 expression was severely decreased in E11.5 Osr1GCE/GCE
limb muscles (Fig. 9a) indicating that the decrease of Col6a3
mRNAs was sufﬁcient to affect COL6 expression in line with
previous in vitro and in vivo observations38, 39. The COL6
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abundance (Fig. 9a), while the Fn1 gene was not deregulated at
the mRNA level (log2 fold change= 0,09). This is consistent with
the impairment of FN deposition and organization in cultured
ﬁbroblasts with reduced or absent COL6 expression40. The
reduction of FN abundance was maintained at E13.5 (Fig. 9b).
Labelling for type XIV Collagen (COL14) also revealed a dis-
ruption of ECM structure (Fig. 9b). COL14 is a ﬁbril-associated
collagen with interrupted triple helices (FACIT) that is important
for assembly of the ﬁbrillary collagens and for crosslinking these
to other ECM components like SLRPs such as Decorin41. This
altogether conﬁrms that the MCT-ECM is disorganized in Osr1
mutants. The ECM components FN and Vitronectin (Vtn), the
latter of which was downregulated in RNA-Seq (Figs. 6c, 7a), are
known to enhance proliferation of cultured myoblasts42, 43. This
emphasizes that a speciﬁc composition of the MCT-ECM is
crucial for regulating embryonic myoblast proliferation. To ana-
lyse if Osr1 cells could inﬂuence myoblast proliferation via their
ECM production, we cultured FACS-isolated Osr1GCE/+ and
Osr1GCE/GCE cells for 10 days to produce an ECM substrate on
the culture plate44. After decellularization, myogenic cells FACS
isolated from new born wild type mice (CD45−;CD31−;Ter119−;
Sca1−;α7-integrin+) were seeded on the ECM substrate and tested
for proliferation. ECM produced by Osr1GCE/+ cells signiﬁcantly
enhanced myogenic cell proliferation in comparison to cultiva-
tion on ECM produced by Osr1GCE/GCE cells. (Fig. 9c). As a
model for an isolated ECM defect we analysed the number of
myogenic cells in Col6a1 mutants, in which production of mature
COL6 is disrupted45. Col6a1 mutants showed a comparable
decrease in myogenic cell number as Osr1 mutants in E11.5 limbs
(Fig. 9d). Together this suggests that Osr1+ cells promote the
expansion of the myogenic progenitor pool via the ECM, with
COL6 as a major constituent and direct Osr1 target.
It was shown before that neonatal limb MCT ﬁbroblasts
supported myogenesis in transwell assays12 indicating that
MCT cells exert at least part of their function via the production
of secreted signalling molecules. We discovered several secreted
signalling factors downregulated in Osr1-deﬁcient embryonic
FAPs, amongst them Cxcl12 as direct Osr1 target. Cxcl12 and its
receptor Cxcr4 are known to be involved in muscle cell
proliferation in vitro46, 47, and both Cxcl12 and Cxcr4 are
involved in mouse limb myogenesis in vivo48, 49. We tested if
Osr1+ cells have the ability to enhance myogenesis via diffusible
components using transwell assays. FACS-isolated E13.5
Osr1GCE/+ or Osr1GCE/GCE cells were seeded into transwell
inserts, myoblasts FACS isolated from new born wild type mice
were seeded into cultivation wells. Osr1GCE/+ cells signiﬁcantly
supported myogenesis as compared to cultivation with Osr1GCE/
GCE cells or cultivation without any cells (Fig. 9e). To further
elucidate to which extent the downregulation of the direct Osr1
target Cxcl12 may be involved in the Osr1 KO phenotype we
analysed mouse mutants for the Cxcl12 receptor Cxcr4 at E14.5
for muscle patterning defects via whole limb immunolabelling.
We observed defects that partly overlap with those of Osr1
mutants, such as reduction on muscle size in the Biceps femoris
muscles (Fig. 9f, g). For the Biceps femoris anterior head the
phenotype of Cxcr4 mutants was exacerbated compared to Osr1
mutants (Fig. 9g). In C2C12 myogenic cells, the Cxcl12/Cxcr4
axis signals via the MAPK/ERK pathway47. The ERK pathway is
also one major downstream component of integrin/focal adhe-
sion signalling triggered by cell-ECM interaction in myogenesis50.
ERK phosphorylation was signiﬁcantly decreased in Lbx1+
myogenic progenitors in Osr1 mutants (Fig. 7h). A downstream
target of ERK in this context is Cyclin D151, 52, which was less
abundant in Lbx1+ nuclei in Osr1 mutants compared to wildtype
(Fig. 7i). Altogether, we propose that Osr1+ embryonal FAPs
positively regulate myoblast proliferation and survival via a
combination of ECM and paracrine signalling.
Discussion
Correct number and distribution of myogenic progenitors ema-
nating from the initial muscle anlagen is essential for embryonic
muscle patterning, a process controlled by local MCT cells8–10.
During this process the MCT cells are thought to create a pro-
myogenic environment13, such as a myogenic niche, that is so far
not well characterized. We show here that Osr1+ cells deﬁne a
population of embryonic FAPs as a subpopulation of MCT. We
demonstrate in vitro that Osr1+ cells are capable of creating such
a niche environment and that Osr1 is essential for their pro-
myogenic capacity in vitro and in vivo.
Our data suggest that Osr1 speciﬁes MCT cell fate and drives a
transcriptional program of MCT-ECM genes in these cells.
Thereby Osr1 directly controls the expression of Col6a1 and
Col6a3, encoding two essential subunits of COL6. The ECM
produced by Osr1+ cells provides an environment for myogenic
cells that promotes their proliferation and survival. Based on the
transcriptome data, we propose that Osr1 drives the transcription
of ECM genes, directly or indirectly, that includes not only a
subset of ECM components such as Collagens, but also compo-
nents essential for collagenous matrix assembly as Lumican,
Matrillin, Decorin and Fibromodulin53. Hence the combined
defect seen in Osr1 mutants should exacerbate effects seen in
mouse models for individual ECM components such as Col6a1
null mice. Indeed, the number of myogenic cells displays a more
pronounced decrease in Osr1GCE/GCE than in Col6a1−/− embryos
at E11.5. In addition, no obvious muscle patterning phenotype
was observed in 3D reconstructions of Col6a1−/− limbs at E14.5
(Supplementary Fig. 11), indicating that myogenic cell numbers
may be caught up later in Col6a1−/− embryos. This is not the case
in Osr1 mutants, where the number and proliferation rate of
Fig. 9 Osr1-deﬁciency impairs the myogenic niche in developing limbs. a Decreased abundance of COL6 and FN (Fibronectin) in proximal (inserts 1 and 3)
and dorsal (inserts 2 and 4) muscle primordia of Osr1-deﬁcient E11.5 limbs. Boxed regions are shown in the numbered panels to the right and are
magniﬁcations of the area. b Reduced abundance of interstitial FN and disarrangement of COL14 in E13.5 Osr1GCE/GCE limb muscles as compared to wild-
type littermate controls. c Extracellular matrix (ECM) produced by Osr1GCE/+ cells, but not ECM produced by Osr1GCE/GCE cells supports myoblast
proliferation (n= 3). d E11.5 Col6a1−/− embryos show a decrease in myogenic progenitor numbers (n= 3). e Transwell assay shows a beneﬁcial effect of
E13.5 Osr1GCE/+ embryonic FAPs (eFAPs) but not Osr1GCE/GCE eFAPs on myogenesis. Transwell culture without eFAPs was used as control (n= 3). f Cxcr4
−/− embryos show muscle defects overlapping with Osr1GCE/GCE embryos. g Sections of Cxcr4+/+ and Cxcr4−/− embryos show almost complete reduction
of the biceps femoris anterior head and hypoplasia of the biceps femoris accessory head. h Decreased phosphorylated ERK (pERK) and (i) CyclinD1 in
myogenic Lbx1+ cells in E11.5 Osr1 mutants (n= 3). j Schematic model of Osr1+ cell function. Osr1+ cells (green) produce chemokines as Cxcl12 and a
speciﬁc extracellular matrix (ECM) supporting myoblast proliferation and survival involving pERK signaling. Cxcl12 in addition likely provides local
migratory cues ensuring correct spatial distribution of myoblasts as a prerequisite for muscle patterning. k Schematic model of limb muscle connective
tissue compartmentalization. Speciﬁc transcription factors (Osr1 and Tcf4 are shown as examples) are expressed regionally in the limb bud with areas of
overlap creating a regionalized code that likely determines the composition of the local niche. Error bars represent s.e.m. T-test: *=p< 0.05; **=p< 0.01;
***=p< 0.001. N-numbers indicate biological replicates, i.e. samples from different specimen in d, h, i or independent assays in c, e
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myogenic cells are still decreased at E13.5 (Supplementary Fig. 8e,
f) and patterning defects are already visible at this stage (Fig. 5d).
In addition to providing a beneﬁcial ECM environment, we
show that Osr1+ embryonic FAPs express signalling molecules
such as Cxcl12 and Bmp4 known to be involved in myogenesis.
Both factors can promote myoblast proliferation46, 47, 54, 55.
Cxcl12/Cxcr4 signalling was also involved in myoblast survival48
thus defective signalling likely contributes to the reduction of the
myogenic pool on top of the ECM defects described above.
Intriguingly, both ECM / focal adhesion signalling as well as
Cxcl12/Cxcr4 signalling can feed into the ERK pathway47, 50,
which we show is strongly impaired in limb myoblasts of Osr1−/−
embryos. Moreover, Cxcl12 promotes myoblast migration in vitro
and in vivo48, 56 and deﬁciency of Cxcr4 impairs myoblast
migration in vivo48. A signiﬁcant early migration phenotype was
however only observed in compound mutants for Cxcr4 and
Gab1, an adaptor and signal mediator protein for c-met48. An
overt muscle patterning phenotype was not demonstrated in
Cxcr4 mutant mice, however they show a mild reduction of
myogenic cell numbers in the limb with increased apoptosis and
altered distribution of myoblasts48. We show here that Cxcr4
mutants show overlapping muscle patterning defects as Osr1
mutants. In case of the Biceps femoris anterior head Cxcr4
mutants show increased severity compared to Osr1 mutants,
which could be expected from a full loss of a receptor as com-
pared to a partial loss of its ligand. We propose that Cxcl12
produced by Osr1+ cells may provide local migration cues for
myogenic cells to reach their correct target areas in the phase of
muscle patterning. A failure of this local mechanism may explain
the absence of myogenic cells in areas normally populated by
myoblasts (Fig. 5b). We therefore conclude that embryonic Osr1+
FAPs are a vital part of a developmental myogenic niche con-
sisting of a muscle-speciﬁc ECM and a favourable signalling
environment. Both components are linked, since composition of
the ECM strongly inﬂuences signalling by secreted molecules57
and both mechanisms can feed into overlapping intracellular
signalling pathways that together maintain the myogenic cell pool
and ensure its correct spatial distribution via directed local
migration (Fig. 9j).
Several transcription factors that are expressed in limb con-
nective tissue were shown to inﬂuence muscle patterning, namely
Tcf4, Tbx4, Tbx5, Hoxa11 and Hoxd1112, 58, 59, although their
modes of action are mostly unclear. None of these genes were
obviously deregulated in Osr1-deﬁcient cells or in Osr1-deﬁcient
limbs (Supplementary Fig. 9d, f) suggesting that Osr1 acts in a
different genetic pathway or downstream of these transcription
factors.
To date, Tcf4 is the most commonly accepted marker for MCT
ﬁbroblasts. We show that during embryonic myogenesis, Tcf4
exhibits a highly regionalized expression, which is mutually
exclusive with Osr1 in many places and overlapping in others
(Fig. 2). This implies that neither Tcf4 nor Osr1 are universal
markers for limb MCT. However, the level of coexpression of
Osr1 and Tcf4 in MCT cells is increased during development, and
Tcf4+ cells can arise from Osr1+ progenitors. This is in accor-
dance with the uniform expression of Tcf4 in MCT of all limb
muscles in neonatal mice as reported by Mathew et al.12. This
suggests that embryonic MCT has a regionalized character where
subpopulations are identiﬁable by the expression of speciﬁc
transcription factors. During development each positional value
in the limb may be characterized by a combination of instructive
transcription factors. This concept suggests a toolbox of tran-
scription factors as easily adaptable determinants of the speciﬁc
local myogenic niche character, which might control the shaping
of individual muscles (Fig. 9k). After the initial patterning phase
this regional MCT subdivision seems to dissolve since at birth
most MCT cells appear to have assumed Tcf4 expression12, while
Osr1 expression is fading.
We show here that the embryonic FAPs are lineage progenitors
of adult muscle interstitial FAPs. Osr1+ cells uniquely contribute
to FAPs and not to other mononuclear cell populations identi-
ﬁable by the FACS protocol we used20. The overall contribution
of developmental Osr1+ cells to adult limb FAPs detected by our
protocol was moderate. This is however not surprising given that
for cell isolation all limb muscles were used, while Osr1 is only
expressed in a subset of muscles during development. Conse-
quently, when counting the contribution of Osr1+ progenitors to
FAPs on sections, a considerably higher contribution rate was
found in individual muscles correlating with developmental Osr1
expression. We chose a protocol of timely limited administration
of moderate TAM doses over either a time-extended adminis-
tration of high TAM doses or constitutive Cre strategies, since our
strategy provides high speciﬁcity, however at the expense of
efﬁcacy. Together, our data show that adult FAPs derive in part
from Osr1+ progenitors, but this is unlikely the only develop-
mental source. Of note we report here quantitative data showing
that a majority of adult FAPs express Tcf4 (Fig. 4d) in agreement
with observations made by Murphy et al.14 suggesting that Tcf4+
muscle connective tissue ﬁbroblasts and FAPs are in fact
largely, however not completely overlapping populations in the
adult muscle interstitium, as proposed previously14, 19. During
muscle regeneration, FAPs are thought to be vitally involved in
creating a speciﬁc, yet mostly undeﬁned, niche for satellite
cells14, 17, 19, 20, 60. Future studies will determine whether adult
FAPs employ similar mechanisms for regenerative myogenesis as
their developmental predecessors.
Methods
Animals. Mice were maintained in an enclosed, pathogen-free facility, and
experiments were performed in accordance with European Union regulations and
under permission from the Landesamt für Gesundheit und Soziales (LaGeSo)
Berlin, Germany (Permission numbers ZH120, G0346/13, G0240/11). Mouse lines
used: Pax3GFP61, Osr1GCE25, R26RmTmG62, R26RLacZ63, Col6a1+/−45 and Cxcr4+/−64.
Cell proliferation analysis. Bromodeoxyuridine (BrdU, Roche) was administered
intraperitoneally to pregnant females (50 mg kg−1) at the desired stage. Embryos
were collected 1 h after BrdU administration for assessing proliferation rates. After
immunolabelling (see below) Lbx1+, Pax7+ or Myod1+ nuclei positive or negative
for BrdU, respectively, were counted in a deﬁned area. To establish the prolifera-
tion rate double positive cells were set in relation to the total cell number positive
for the respective marker.
Tamoxifen administration and Osr1 cell lineage tracing. Tamoxifen (Sigma
Aldrich) was dissolved in a 1:10 ethanol/sunﬂower oil mixture. For embryonic
lineage tracing, pregnant R26RmTmG/mTmG females that had been bred to Osr1GCE/
+ males were injected with 150 µl of a 20 mgmL−1 Tamoxifen stock. Tissues were
collected at E18.5. Upon CreERt2 activation, the mTmG allele is converted as to
switch cells from membrane tomato (mT) expression to membrane eGFP (mG)
expression. Importantly, mG expression driven by the CMV enhancer/beta-actin
core promoter cassette can be visualized by direct microscopy without antibody
labelling. This, and the membrane localization, differentiates mG expressed from
the R26RmTmG allele from the cytoplasmic eGFP expressed from the Osr1GCE allele,
which was not detectable without prior immunolabelling for GFP under the
experimental conditions used here.
For postnatal lineage tracing, new born Osr1GCE/+;R26RLacZ/+or Osr1GCE/+;
R26RmTmG/+ pups were injected subcutaneously into the neck fold with 25 µl of a
3 mgml−1 Tamoxifen stock. Adult tissue was collected at 12 weeks of age.
Expression of beta-Galactosidase (bGal) from the R26RLacZ allele was detected by
immunolabelling (see below).
Tissue preparation. For immunolabelling, embryonic tissues were ﬁxed in 4%
PFA for 2 h at RT and treated with successive 15 and 30% (w/v) sucrose (Roth)
solutions before O.C.T. (Sakura) cryo-embedding in a chilled ethanol bath.
Embryonic tissue was sectioned at 12 μm thickness and stored at −80 °C until use.
Adult muscle tissues were directly embedded in gum Tragacanth 6% (w/v) (Sigma-
Aldrich) and ﬂash frozen using a chilled (−160 °C) isopentane (Carl Roth) bath.
Adult tissues were cut at 7 µm thickness and ﬁxed in 4% PFA for 5 min at room
temperature. For section in situ hybridization tissue was ﬁxed in 4%
ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/s41467-017-01120-3
14 NATURE COMMUNICATIONS |8:  1218 |DOI: 10.1038/s41467-017-01120-3 |www.nature.com/naturecommunications
paraformaldehyde dissolved in diethylpyrocarbonate (DEPC)-treated PBS for 2 h at
room temperature. Tissue was sectioned at 10 μm thickness and stored at −80 °C
until use. For whole-mount in situ hybridization embryos were ﬁxed in 4% PFA/
DEPC-PBS at 4 °C overnight. After ﬁxation embryos were washed with DEPC-PBS
and 0,1% Tween-20 (PBST) for 30 min on ice. Embryos were dehydrated in
Methanol and stored at −20 °C until use.
Immunolabelling. Permeabilization of sections was performed in 0.3% (v/v) Triton
X-100 (Sigma Aldrich) in phosphate buffer (PBS) for 10 min. Sections from adult
tissues were blocked with 5% (w/v) bovine serum albumin (Sigma Aldrich) in PBS.
Antigen retrieval was performed where necessary: for Pax7 immunostaining, sec-
tions were treated for 6 min in −20 °C chilled methanol and subsequently washed
in PBS. Further epitope retrieval was performed by a treatment with 1 mM
Ethylendiaminetetraacetic acid (Roth) at 95 °C for 10 min. For BrdU detection
sections were treated using 7.5% 1 N HCL at 37 °C during 30 min. Cleaved Caspase
3 antibody staining was preceded by an antigen retrieval consisting of a treatment
with citrate buffer, 10 mM sodium citrate (Roth) pH 6, at 95 °C for 10 min. Sections
were blocked with 5% horse serum, 5 mgmL−1 blocking reagent (Perkin Elmer)
and 0.1% Triton X-100 in PBS for 1 h at RT. Primary antibodies were incubated at
4 °C overnight, followed by secondary antibody staining of 1 h at room tempera-
ture. Antibodies used for these experiments are listed in Supplementary Tables 3
and 4. Specimens were counterstained with 5 µg µL−1 4′,6-diamidino-2-pheny-
lindole (DAPI; Invitrogen) and mounted with FluoromountG (SouthernBiotech).
For immunolabelling of cells samples were ﬁxed using 4% PFA for 2 h at room
temperature. Samples were blocked and permeabilized with 5% horse serum, 5 mg
mL−1 blocking reagent (Perkin Elmer) and 0.1% Triton X-100 in PBS for 1 h at RT
followed by primary and secondary antibody incubation as above. Cytospin-
collected cells were ﬁxed with 4% PFA for 10 min at 4 °C and subjected to
immunolabelling as above.
In situ hybridization. Digoxygenin-labelled Riboprobes for in-situ hybridization
were made with the DIG RNA labelling kit (Roche: 11175033910) according to the
manufacturer’s instructions. Probes used in this study are listed in Supplementary
Table 5.
For section in-situ hybridization cryosections were washed three times with
DEPC-PBS and treated with acetylation buffer (0,75% triethanolamine, 0,15%
hydrogen chloride and 0,2% acetic anhydride in DEPC-H2O) for 10 min under
agitation. Acetylation buffer was washed out with DEPC-PBS. Sections were
incubated for at least 2 h at room temperature in pre-hybridization buffer (50%
Formamide, 5x concentrate sodium saline citrate buffer (SSC) pH 4.5, 1% SDS,
0,1% Tween-20). Riboprobes were diluted in hybridization buffer (10 mM Tris pH
7.5, 600 mM NaCl, 1 mM EDTA, 0,25% SDS, 10% Dextran sulfate, 1x Denhardt´s,
200 µg/ml yeast tRNA and 50% Formamide) and added to the slides. Slides were
covered with a glass coverslip followed by hybridization at 65 °C overnight in a
humidiﬁed chamber. Coverslips were removed by washing in 2x SSC for 5 min at
room temperature. Unhybridized RNA probe was removed by washing the slides
twice in 2x SSC at 65 °C for 30 min followed by two washing steps in MABT-buffer
(100 mM Maleic acid pH 6, 0.1% Tween) for 30 min at room temperature. Slides
were blocked in 500 μl blocking solution (MABT-buffer + 5% blocking reagent
Roche 1109617001) for 1 h at room temperature in a PBS humidiﬁed chamber.
Anti-DIG antibody (Roche: 11093274910) was dissolved 1:2000 in blocking
solution, added to the sections and incubated overnight at room temperature.
Antibody solution was washed off with MABT ﬁve times for 30 min at room
temperature. Slides were treated twice with NTMT-buffer (100 mM NaCl, 100 mM
Tris pH 9.5, 50 mM MgCl2 and 0,1% Tween-20) for 10 min at room temperature
followed by signal detection with detection solution (5 μg 4-Nitro blue tetrazolium
chloride (NBT) and 2.6 μg 5−bromo-4-chloro-3-indolyl-phosphate (BCIP)
dissolved in NTMT). Signal detection was performed at 37 °C in a light protected
chamber. Staining reaction was stopped by washing the slides in PBS for 5 min. If
further antibody staining was desired, sections were directly processed for
immunolabelling (see above).
For whole-mount in-situ hybridization embryos were rehydrated in DEPC-PBS
and bleached in 6% hydrogen peroxide in PBST for 1 h on ice. For permeabilization
embryos were treated with 20 mg/ml proteinase K at room temperature for 8 min.
Embryos were washed twice in DEPC-PBST and post-ﬁxed for 20 min in 4% PFA
in DEPC-PBS at room temperature followed by brief washing in DEPC-PBST. For
pre-hybridization embryos were incubated in L1−Buffer (50% Formamide, 5x SSC
pH 4.5, 1% SDS and 0,1% Tween-20) for 10 min at 68 °C. Then embryos were
incubated in H1-Buffer (L1-Buffer supplemented with 0,1 mg/ml tRNA and 0,05
mg/ml Heparin) for 2 h at 68 °C. Riboprobes were diluted in H1-Buffer and added
to embryos in 2 ml cryovials followed by hybridisation at 68 °C overnight.
Unbound probe was removed by washing the embryos 3 times for 30 min in 68 °C
in pre-warmed L1-Buffer followed by 3 times washing in L2-Buffer (50%
Formamid, 2x SSC pH 4.5, 0,1% Tween-20 in DEPC-water) for 30 min at 68 °C.
Embryos were then washed for 15 min at 68 °C with L3-Buffer (L3-Buffer: 2x SSC
pH 4.5, 0,1% Tween-20 in DEPC water) followed by washing in a 1:1 solution of
L3-Buffer and RNase buffer (500 mM NaCl, 10 mM Tris pH 7.5, 0,1% Tween-20)
for 5 min at room temperature. Embryos were treated with a solution of 100 µg/ml
RNase A in RNase buffer for 1 h at 37 °C. RNase solution was washed out 3 times
for 5 min each at room temperature with Tris saline buffer (8 g/L NaCl, 0,2 g/L
KCl, 3 g/L Tris pH 7.4) supplemented with 1% Tween-20. Embryos were blocked in
blocking solution (2% fetal calf serum, 2 mg/ml bovine serum albumin dissolved in
TBST) at room temperature for 2 h. Anti-DIG antibody (Roche: 11093274910) was
dissolved 1:5000 in blocking solution and incubated overnight under rotation at 4 °
C. Embryos were washed in TBST supplemented with alkaline phosphatase
inhibitors 0,05% Levamisole/Tetramisole (Sigma Aldrich L9756) 5 times for 5 min
each, and again 8 times for 30 min each. Embryos were then incubated in alkaline
phosphatase buffer (100 µM NaCl, 50 mM MgCl2, 0,1% Tween-20, 100 mM Tris
pH 9.5 and 0,5 mg/ml Levamisole/Tetramisole) for 20 min. Signal detection was
performed with 225 µg/ml NBT and 87,5 µg/ml BCIP dissolved in alkaline
phosphate buffer at room temperature under light protection. Signal development
was stopped by washing for 3 times 10 min each in alkaline phosphate buffer
followed by ﬁxation in 4% PFA, 0,2% glutaraldehyde and 5 mM EDTA for long
term storage.
Cell isolation and ﬂow cytometry. Limbs of E13.5 Osr1GCE/+ or Osr1GCE/GCE
embryos were minced in 500 µL high-glucose Dulbecco’s modiﬁed eagle medium
(DMEM, Invitrogen) using a small scissor. Further enzymatic digestion of the
tissue was performed using 10 mgml−1 of Collagenase (Collagenase NB 4 G proved
grade, SERVA ElectrophoresisTM) in DMEM medium supplemented with 2 mM
CaCl2 and MgCl2 with vigorous shaking at 37 °C for 45 min. After digestion, tissue
extracts were washed and resuspended in high-glucose DMEM medium. Cell
suspensions were passed through a 100-µm cell strainer (Miltenyl Biotec) and
collected by centrifugation at 300 g for 5 min. For ﬂow cytometry analysis or cell
sorting, cell suspensions were blocked for 5 min. in 5% mouse serum (Sigma
Aldrich). Antibody labelling (antibodies see Supplementary Table 3) was per-
formed for 60 min at 4 °C. Before ﬂow cytometry cell suspensions were washed,
collected by centrifugation at 300 g for 5 min and passed through a 35-µm cell
strainer ﬁlter (BD Biosciences). To assess viability, cells were stained with propi-
dium iodide (1 μg ml–1, eBioscience) immediately before sorting or analysis.
For cell isolation from adult muscles whole hind limb muscles were carefully
isolated, roughly minced and digested in high-glucose DMEM medium containing
2,5 mg/ml Collagenase A (Roche) for 75 min at 37 °C with vigorous shaking. 2 IU/
ml of Dispase II (Sigma Aldrich) were added to the digestion solution and muscle
lysates were digested for further 30 min. Muscle slurries were passed 10 times
through a 20 G syringe (BD Bioscience) and a 70-µm cell strainer. Cells were
collected by centrifugation at 300 g for 5 min and resuspended in staining buffer
consisting of 500 µl Hank´s balanced salt solution (HBSS, Thermo Fisher scientiﬁc),
0.4% bovine serum albumin (Sigma Aldrich) and 20 µg/ml Gentamycin (Serva
Electrophoresis). Cells were labelled with antibodies (Supplementary Table 6) on
ice for 30 min and washed twice with staining buffer previous to FACS sorting.
Propidium iodide was used as a viability dye.
Sorts and analyses were performed on a FACS Aria II (BD Biosciences). Data
were collected using FACSDIVA software. Biexponential analyses were performed
using FlowJo 10 (FlowJo LLC) software. Analysis was performed on three
independent biological replicates (i.e. cells FACS isolated from three different
embryos). Sorting gates were deﬁned based on unstained controls. Cells were
sorted either into 1 ml high-glucose DMEM warmed to 37 °C for further culturing
or directly into buffer RLT (Qiagen RNeasy kit) for RNA extraction.
Cell culture. FACS isolated cells were collected by centrifugation at 300 g for 5 min
and seeded on 2% MatrigelTM (BD Biosciences) coated glass coverslips (Thermo
scientiﬁc) previously exposed to 30 min of UV light. Before differentiation
induction cells were then expanded for 3 days in growth medium (high-glucose
DMEM medium with 10% fetal bovine serum (FBS, Biochrom)). FACS isolated
cells designated for adipogenic differentiation were ﬁrst expanded for 3 days in
medium containing 60% low-glucose DMEM (Invitrogen), 40% MCDB201 Media
(Sigma Aldrich), 10% FBS, 0.4 ng mL−1 dexamethasone, 29 μg mL−1 L-ascorbic
acid 2-phosphate, 1x ITS liquid media supplemented mix, 1x Linoleic acid-albumin
(Sigma Aldrich) and freshly added growth factors: 10 ng mL−1 EGF, 10 ng mL−1
PDGF-BB (PeproTech), 10 ng mL−1 LIF (Millipore) and 5 ng mL−1 bFGF (Sigma
Aldrich).
Myogenic differentiation was induced by culturing cells for 5–7 days in high-
glucose DMEM medium with 2% horse serum (Vector Labs). For ﬁbrogenic
differentiation cells were cultured in low-glucose DMEM medium with 2% FBS
supplemented with 1 ng mL−1 TGFβ1 (PeproTech) for 3 days followed by 3 days in
differentiation medium without TGFβ1. For osteogenic differentiation, we used
low-glucose DMEM medium supplemented with 100 nM dexamethasone, 10 mM
β-glycerophosphate, 0.2 mM ascorbic acid and 50 ng ml−1 L-thyroxine (Sigma
Aldrich) and differentiated the cells for 40 days with medium change every two
days. For chondrogenic differentiation we seeded 20 µl droplets of 105 cell
suspensions on uncoated coverslips. Cultures were grown in high-glucose DMEM
medium with 10% FBS and supplemented with 10 ng mL –1 TGFβ1, 1 µM ascorbic
acid, 100 nM dexamethasone and 10x ITS liquid media supplemented mix (Sigma
Aldrich) for 14 days. Medium was changed every 2–4 days. For adipogenic
differentiation cells were cultured for 48 h in 60% low-glucose DMEM (Invitrogen),
40% MCDB201 Media (Sigma Aldrich), 10% FBS supplemented with 1 μM
dexamethasone, 0.5 µM isobutylmethylxanthine, 5 μg mL–1, 50 μM indomethacin,
1 nM triiodo-L-thyronine sodium salt (Sigma Aldrich) and insulin (Roche).
Thereafter cells were cultured for 7 days in 60% low-glucose DMEM (Invitrogen),
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40% MCDB201 (Sigma Aldrich), 10% FBS. Differentiation assays were performed
on three independent biological replicates (i.e. cells FACS isolated from three
different embryos).
ECM deposition assay was conducted as follows: Osr+ cells were isolated via
FACS sorting from E13.5 Osr1GCE/+ or Osr1GCE/GCE embryos and plated on 24
well-plates (52.500 cells/well). Cells were kept in growth medium (10% FCS,
DMEM 4,5 g Glucose, 1% Penicillin/Streptomycin, 1% L-Glutamine) until they
reached 80% conﬂuence. Cells were further cultured in low serum medium (2%
FCS, DMEM 4,5 g Glucose, 1% Penicillin/Streptomycin, 1% L-Glutamine) for
14 days. Decellularization was conducted via a snap freeze/thaw procedure. Cells
were washed once with H2O, then wells were ﬁlled with 200μl of H2O and plates
were stored for 40 min at −80 °C. Plates were thawed in a 37 °C water bath for 30 s.
Then the wells were ﬁlled with 800 μl growth medium (room temperature) and
transferred to 37 °C. Myoblasts were collected from 3–4 days old neonate mice via
FACS (CD45−;CD31−;Ter119−;Sca1-;α7-integrin+). Myoblasts were seeded on the
ECM (2,5 × 105 cells/well). As control Myoblasts were seeded in wells coated with
10% Matrigel (Corning). Myoblasts were then cultured in proliferation medium
(20% FCS, 10% horse serum, DMEM 4,5 g Glucose, 1% Penicillin/Streptomycin,
1% L-Glutamine) for 16 h. Then cells were ﬁxed with 4% PFA and immunolabeled
for Pax7 and Ki67.
Transwell assay was performed as follows: 2,5 × 105 FACS-isolated p3–4
myoblasts (see above) were seeded on glass coverslips coated with MatrigelTM and
allowed to settle for 24 h in myogenic proliferation medium (DMEM 4,5 g Glucose,
1% Penicillin/Streptomycin, 1% L-Glutamine, 10% horse serum, 20% FBS) in 24
well plates. The day before Osr1+ cells were isolated via FACS from E13.5 Osr1GCE/
+ or Osr1GCE/GCE embryos. 8 × 104 GFP+ cells were seeded into transwell inserts
and cultured for 24 h in growth medium. On the next day, growth medium was
replaced by myogenic differentiation medium (DMEM 4,5 g Glucose, 1%
Penicillin/Streptomycin, 1% L-Glutamine, 2% horse serum) for preconditioning.
After 24 h the transwell inserts containing the GFP+ cells together with the
preconditioned myogenic differentiation medium were transferred to 24 well plates
containing the myoblasts. As control, myoblasts were cultured with empty
transwell inserts. Transwell coculture was performed for 14 days with medium
change every second day. Myogenic differentiation was analyzed by
immunolabeling for Myosin heavy chain (MyHC). For quantiﬁcation an area of
1,75mm2 were analyzed and only MyHC+DAPI+ cells were counted.
Staining procedures. To stain lipids, cell cultures were stained with Oil Red O
(Sigma Aldrich) 0.5% (w/v) 1 h at RT. Lipids on sections were stained 15 min in Oil
Red O staining solution at RT. Calcium accumulation after osteogenic differ-
entiation was assessed by Alizarin Red (Sigma Aldrich) staining using a 1% (v/v)
staining solution (from a stock solution of 13.3 mg mL−1 at pH 6.5) applied during
30 min. For assessing chondrogenic differentiation cultures were stained using
Alcian Blue (Sigma Aldrich) staining solution 10 mgmL−1 dissolved in 0.1 N
hydrochloric acid (Carl Roth) applied during 30 min at RT.
Imaging. Cell cultures were documented with a Nikon Eclipse TS 100 microscope,
a Leica DMR microscope or a Zeiss SteREO Discovery V12 stereomicroscope.
Confocal images of immunolabelled sections or cells were taken using the confocal
laser scanning microscope system LSM710 (Zeiss). Images were captured using
Axio Vission Rel. 4.8 and Zen 2010 (Zeiss).
Cell quantiﬁcation. Quantiﬁcation of FACS-isolated Osr1+ cells after immunola-
belling (cytospin or growth medium culture) was performed on three independent
biological replicates (i.e. cells FACS isolated from three different embryos).
Quantiﬁcation of speciﬁc cell markers on sections after immunolabelling was
assessed on at least 4 serial sections in 30 µm intervals for each biological replicate
with a minimum of 3 replicates (exact values given in ﬁgures, in each case n stands
for one biological replicate). In Fig. 3g the interval was reduced to 10 µm. For each
experiment serial sections of the whole limb were immunolabelled, and only sec-
tions containing comparable regions were used for quantiﬁcation. At least ﬁve
sections for each biological replicate were counted. Student’s t-test was performed
using Prism 5 (GraphPad) software. Error bars in all ﬁgures, including supple-
mentary information, represent the mean ± standard error of the mean (s.e.m).
3D reconstruction of embryonic limb muscles. Whole mount immuno-
ﬂuorescence labelling on E14.5 embryonic limbs was performed as previously
described65. For 3D reconstruction, images captured on a LSM710 confocal
microscope (Zeiss) were analysed using the programs Amira® (FEI visualization
Sciences Group) and Fluorender® (University of Utah).
Quantitative real-time PCR. RNA isolation was performed using RNeasy mini
kits (Qiagen), and RNA quantiﬁcation was assessed using a ND2000 spectro-
photometer (Nanodrop). Reverse transcription was performed using the High
Capacity cDNA Reverse Transcription Kit (Applied Biosystems). Gene expression
analysis was conducted using Taqman Gene Expression Assays (Applied
Biosystems), on a 7900HT Real Time PCR system (Applied Biosystems). Primer
sequence information is provided in Supplementary Table 7. Data were acquired
and analysed using SDS 2.0 software (Applied Biosystems). Quantitative RT-PCR
analyses were performed on at least four independent biological samples (embryos)
different from those used for RNA-Sequencing.
RNA-sequencing. Total RNAs were extracted from Osr1+ cells isolated by FACS-
sorting from E13.5 limbs of two Osr1GCE/+ and two Osr1GCE/GCE embryos by using
the RNeasy mini kit (Qiagen). Libraries were prepared by using the TruSeq RNA
Library Preparation Kit v2 according to Illumina’s intructions and subjected to
high-throughput sequencing by using the Illumina HiSeq 2500 technology. 65–75
million of 50-bp paired-end reads were generated with a mean insert size of 150 bp
and mapped against the genome of Mus musculus version mm9 by using
TopHat266 and the UCSC gene model annotation from iGenome as guide (default
parameters, except for the mean inner distance set at 150 and the minimum intron
length set at 50). Aligned fragments per gene were counted by using the inter-
section strict mode from HTSeq67. Raw fragment counts showed a very high
Pearson correlation (>0.99) between both biological replicates for each condition.
Differential expression analysis was performed by using DESeq268 and a false
discovery rate (FDR; alpha) of 0.05. Genes were considered as being differentially
expressed between the Osr1GCE/+ and Osr1GCE/GCE conditions if the Benjamini-
Hochberg adjusted p-value (padj) was below 0.1. Transcripts per million (TPM)
abundances were calculated from the mean normalized fragment counts given by
DESeq2 for both Osr1GCE/GCE samples. Gene ontology (GO) analyses were carried
out by using the DAVID functional annotation tools69. Raw fastq and count data
were uploaded on the Gene Expression Omnibus (GEO) database under the
accession number GSE78056.
Chromatin immunoprecipitation. Genomic regions up to 20 kb upstream of
putative direct Osr1 targets were screened for consensus Osr1 binding sites in the
UCSC browser (GRCm38/mm10). For Cxcl12, in addition the gene desert 5′ of the
ﬁrst exon was screened for Osr1 binding sites speciﬁcally within DNAseI hyper-
sensitive regions (putative enhancers). Distant binding sites were conﬁrmed to be
included into the same topology-associated domain as Cxcl12 (http://promoter.bx.
psu.edu/hi-c/view.php)70 PCR primer were designed overlapping or closely adja-
cent to binding sites. Regions without consensus binding sites located in the
vicinity were chosen as controls.
Lentiviral particles carrying an Osr1-tripleFLAG construct under the ubiquitin
c (UbC) promoter or carrying a GFP expression construct as control were
purchased from AMSBio (Abingdon, UK). For ChIP assays, MEFs were isolated
from E13.5 C57Bl6 limbs as described above (Cell isolation). For infection 3 ×
105–4 × 105 cells were resuspended in 5 ml 37 °C pre-warmed growth medium
(high glucose DMEM medium supplemented with 10% FBS). Infection was
achieved using spinoculation of suspension cells. Polybrene and lentoviral particles
were added to the medium. Cells and virus particles were centrifuged for 60 min at
300 g before seeding. Medium was changed at the next day. Chromatin
immunoprecipitation (ChIP) was performed as follows: cells were ﬁxed on a
conﬂuent 10 cm dish for 10 min with 10 ml of 1% Formaldehyde (Sigma Aldrich)
in growth medium. Chromatin cross-linking was quenched adding 550 µl of 2.5 M
Glycine. Medium was removed and cells were washed twice with DPBS. Cells were
lysed and removed with a scratcher. Nuclei were collected in 900 µl sonication
buffer and split into 3 × 1.5 ml TPX tubes (Biogenade). Cells were sonicated for 20
cycles in a Bioruptor (Biogenade). 30 µg of sonicated chromatin was used per ChIP.
8 µg of anti-FLAG antibody was added to the 30 µg of sonicated chromatin and
incubated under rotation overnight at 4 °C. 30 µl of protein G beads (Invitrogen)
were added to the Chromatin-Antibody mixture and incubated under rotation at 4
°C overnight. Chromatin bound to the Dynabeads-antibody complex was isolated
using vigorously shaking conditions at 65 °C for 30 min and further de-crosslinked
overnight at 65 °C. Proteins bound to the chromatin were removed with a 60 min
treatment at 55 °C of Proteinase K (500 mg/ml) and RNA with a 30 min treatment
at 37 °C with RNase A (Sigma Aldrich). Genomic DNA from sonicated chromatin
was used as an input DNA and DNA isolated after ChIP as pulldown DNA.
Pulldown was evaluated by Gel electrophoresis and quantitative real-time PCR,
with 3 independent pulldown experiments. Primer sequences are provided in
Supplementary Table 8. Uncropped lanes from representative gel electrophoresis
images can be found in Supplementary Fig. 12.
Data availability. All data supporting the ﬁndings of this study are available within
the article and its supplementary information ﬁles or from the corresponding
author upon reasonable request. Raw fastq and count data from RNA Sequencing
experiments have been deposited in the Gene Expression Omnibus (GEO) database
under accession code GSE78056.
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